Objectives: To compare simple conventional treatment with the addition of hyperbaric oxygen therapy (HBOT) to conventional therapies in the treatment of Fournier's gangrene (FG). Methods: A retrospective study of clinical data was performed by reviewing 28 cases of FG from January 2004 to December 2013 at Xiangya Hospital, Central South University. Among them, 12 patients were treated with the conventional therapy (non-HBOT group) and the other 16 cases were combined with hyperbaric oxygen therapy besides conventional therapy (HBOT group). All patients were followed up for 2 months to assess the therapeutic effect. The analyzed data included age, Fournier gangrene severity index (FGSI) score, number of surgical debridement, indwelling drainage tube time, length of stay (LOS), effective time, and curative time. Results: The mortality rate was lower in the HBOT group at 12.5% (2/16) compared to the non-HBOT group, which was 33.3% (4/12). The difference in the number of surgical debridement, indwelling drainage tube time, and curative time between were significantly lower in the HBOT group compared to the non-HBOT group. Conclusions: Our preliminary research suggests that the effect of combining hyperbaric oxygen therapy with conventional therapy offers considerable advantage in the management of Fournier's gangrene. Multicenter studies with a larger sample size are required to confirm these observations.

Keywords:
Fournierߣs gangrene, Comprehensive treatment, Hyperbaric oxygen therapy, Early debridement, Length of stay
1.
Shyam DC, Rapsang AG: Fournier's gangrene. Surgeon 2013;11:222-232.
2.
Mallikarjuna MN, Vijayakumar A, Patil VS, et al: Fournier's gangrene: current practices. ISRN Surg 2012;2012:942437.
3.
Yanar H, Taviloglu K, Ertekin C, et al: Fournier's gangrene: risk factors and strategies for management. World J Surg 2006;30:1750-1754.
4.
Weinfeld AB, Kelley P, Yuksel E, et al: Circumferential negative-pressure dressing (VAC) to bolster skin grafts in the reconstruction of the penile shaft and scrotum. Ann Plast Surg 2005;54:178-183.
5.
Kuo CF, Wang WS, Lee CM, et al: Fournier's gangrene: ten-year experience in a medical center in northern Taiwan. J Microbiol Immunol Infect 2007;40:500-506.
6.
Singh G, Sinha SK, Adhikary S, et al: Necrotising infections of soft tissues - a clinical profile. Eur J Surg 2002;168:366-371.
7.
Altarac S, Katušin D, Crnica S, Papeš D, Rajković Z, Arslani N: Fournier's gangrene: etiology and outcome analysis of 41 patients. Urol Int 2012;88:289-293.
8.
Aridogan IA, Izol V, Abat D, Karsli O, Bayazit Y, Satar N: Epidemiological characteristics of Fournier's gangrene: a report of 71 patients. Urol Int 2012;89:457-461.
9.
Bjurlin MA, O'Grady T, Kim DY, et al: Causative pathogens, antibiotic sensitivity, resistance patterns, and severity in a contemporary series of Fournier's gangrene. Urology 2013;81:752-758.
10.
Laor E, Palmer LS, Tolia BM, et al: Outcome prediction in patients with Fournier's gangrene. J Urol 1995;154:89-92.
11.
Yilmazlar T, Ozturk E, Alsoy A, Ozguc H: Necrotizing soft tissue infections: APACHE II score, dissemination, and survival. World J Surg 2007;31:1858-1862.
12.
Erol B, Tuncel A, Hanci V, et al: Fournier's gangrene: overview of prognostic factors and definition of new prognostic parameter. Urology 2010;75:1193-1198.
13.
Grabe M, Bjerklund-Johansen TE, Botto H: Guidelines on Urological Infections. European Association of Urology, 2011, pp 76-78.
14.
Sorensen MD, Krieger JN, Rivara FP, et al: Fournier's gangrene: population based epidemiology and outcomes. J Urol 2009;181:2120-2126.
15.
Horta R, Cerqueira M, Marques M, Ferreira P, Reis J, Amarante J: [Fournier's gangrene: from urological emergency to plastic surgery]. Actas Urol Esp 2009;33:925-929.
16.
Kindwall EP, Gottlieb LJ, Larson DL: Hyperbaric oxygen therapy in plastic surgery: a review article. Plast Reconstr Surg 1991;88:898-908.
17.
Mehl AA, Nogueira Filho DC, Mantovani LM, Grippa MM, Berger R, Krauss D, et al: Management of Fournier's gangrene: experience of a university hospital of Curitiba. Rev Col Bras Cir 2010;37:435-441.
18.
Hollabaugh RS Jr, Dmochowski RR, Hickerson WL, Cox CE: Fournierʼs gangrene: therapeutic impact of hyperbaric oxygen. Plast Reconstr Surg 1998;101:94-100.
19.
Shupak A, Shoshani O, Goldenberg I, Barzilai A, Moskuna R, Bursztein S: Necrotizing fasciitis: an indication for hyperbaric oxygenation therapy? Surgery 1997;118:873-878.
20.
Tharakaram S, Keckes K: Necrotising fasciitis: a report of 5 patients. Int J Dermatol 1988;27:585-588.
21.
Martinschek A, Evers B, Lampl L, Gerngroß H, Schmidt R, Sparwasser C: Prognostic aspects, survival rate, and predisposing risk factors in patients with Fournier's gangrene and necrotizing soft tissue infections: evaluation of clinical outcome of 55 patients. Urol Int 2012;89:173-179.
22.
Kindwall EP: Uses of hyperbaric oxygen therapy in the 1990s. Cleve Clin J Med 1992;59:517-528.
23.
Capelli-Schellpfeffer M, Gerber GS: The use of hyperbaric oxygen in urology. J Urol 1999;162:647-654.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.